Virtus ETF Advisers LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.16 - $15.1 $96,157 - $177,938	-11,784 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $7,817 - $11,845	-698 Reduced 5.59%	11,784 $174,000
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $61,651 - $91,180	4,988 Added 66.56%	12,482 $165,000
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $6,826 - $9,771	-399 Reduced 5.06%	7,494 $131,000
Q2 2021 Aug 10, 2021	BUY	$23.12 - $29.91 $182,486 - $236,079	7,893 New	7,893 $189,000
Q4 2019 Feb 13, 2020	SELL	$10.31 - $17.81 $130,813 - $225,973	-12,688 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$11.6 - $21.67 $8,201 - $15,320	-707 Reduced 5.28%	12,688 $147,000
Q2 2019 Aug 13, 2019	BUY	$18.44 - $30.89 $247,003 - $413,771	13,395 New	13,395 $297,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.